LeJeune Puetz Investment Counsel’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,200
| Closed | -$110K | – | 193 |
|
|
2022
Q2 | $110K | Hold |
2,200
| – | – | 0.04% | 188 |
|
|
2022
Q1 | $112K | Sell |
2,200
-1,400
| -39% | -$71.3K | 0.04% | 187 |
|
|
2021
Q4 | $219K | Sell |
3,600
-600
| -14% | -$36.5K | 0.07% | 148 |
|
|
2021
Q3 | $202K | Hold |
4,200
| – | – | 0.07% | 150 |
|
|
2021
Q2 | $221K | Hold |
4,200
| – | – | 0.08% | 148 |
|
|
2021
Q1 | $208K | Hold |
4,200
| – | – | 0.08% | 150 |
|
|
2020
Q4 | $204K | Hold |
4,200
| – | – | 0.09% | 145 |
|
|
2020
Q3 | $211K | Hold |
4,200
| – | – | 0.1% | 133 |
|
|
2020
Q2 | $214K | Hold |
4,200
| – | – | 0.11% | 129 |
|
|
2020
Q1 | $184K | Hold |
4,200
| – | – | 0.11% | 134 |
|
|
2019
Q4 | $211K | Hold |
4,200
| – | – | 0.1% | 143 |
|
|
2019
Q3 | $195K | Sell |
4,200
-1,138
| -21% | -$52.8K | 0.1% | 142 |
|
|
2019
Q2 | $182K | Hold |
5,338
| – | – | 0.09% | 144 |
|
|
2019
Q1 | $186K | Hold |
5,338
| – | – | 0.1% | 140 |
|
|
2018
Q4 | $182K | Hold |
5,338
| – | – | 0.11% | 130 |
|
|
2018
Q3 | $188K | Hold |
5,338
| – | – | 0.11% | 133 |
|
|
2018
Q2 | $168K | Hold |
5,338
| – | – | 0.1% | 138 |
|
|
2018
Q1 | $168K | Hold |
5,338
| – | – | 0.1% | 127 |
|
|
2017
Q4 | $181K | Sell |
5,338
-97
| -2% | -$3.29K | 0.11% | 124 |
|
|
2017
Q3 | $213K | Buy |
5,435
+4,930
| +976% | +$193K | 0.14% | 118 |
|
|
2017
Q2 | $190K | Hold |
505
| – | – | 0.13% | 122 |
|
|
2017
Q1 | $180K | Hold |
505
| – | – | 0.13% | 121 |
|
|
2016
Q4 | $161K | Buy |
+505
| New | +$161K | 0.12% | 122 |
|